A 55-year-old male patient, known since childhood as having type 2 von Willebrand disease (vWD), with very mild symptoms, with one or even less annualized bleeding rate (ABR), was treated on-demand with FVIII containing vWF. This evidence concerns the gene VWF and von Willebrand disease (hereditary or acquired).